Richard Brudnick

Insider Reports History

Location
Waltham, MA
Signature
/s/ Christian Schmid, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Richard Brudnick:

Form 4 holding Director

VOLITIONRX LTD

Security class
Common Stock
Shares / value
27,936
Estimated value
$23,187
Report date
12 Jan 2023
Price
$0.8300
Ownership
Direct
Form 4 holding Chief Business Officer

Prime Medicine, Inc.

Security class
Stock Option (right to buy)
Shares / value
225,000
Estimated value
Report date
27 Feb 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Officer title: Chief Business Officer and Head of Corporate Strategy

Codiak BioSciences, Inc.

Security class
Restricted Stock Units
Shares / value
16,275
Estimated value
Report date
16 Feb 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Officer title: Chief Business Officer and Head of Corporate Strategy

Codiak BioSciences, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
10,850
Estimated value
Report date
16 Feb 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Richard Brudnick

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .